Julie Papanek Grant - 26 May 2021 Form 3 Insider Report for Day One Biopharmaceuticals, Inc. (DAWN)

Role
Chair of the Board
Signature
/s/ Julie Grant
Issuer symbol
DAWN
Transactions as of
26 May 2021
Net transactions value
$0
Form type
3
Filing time
26 May 2021, 21:38:22 UTC
Previous filing
02 Jun 2021
Next filing
12 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding DAWN Common Stock 465,000 26 May 2021 Direct
holding DAWN Common Stock 3,245,869 26 May 2021 By Canaan XI, L.P. F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding DAWN Series A Preferred Stock 26 May 2021 Common Stock 7,328,497 By Canaan XI, L.P. F1, F2
holding DAWN Series B Preferred Stock 26 May 2021 Common Stock 148,279 By Canaan XI, L.P. F1, F3
holding DAWN Stock Option (right to buy Common Stock) 26 May 2021 Common Stock 63,000 $16.00 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents securities held by Canaan XI, L.P. ("Canaan LP"). The Reporting Person, as a non-managing member of Canaan LP's general partner, Canaan Partners XI LLC, disclaims Section 16 beneficial ownership of such securities except to the extent of her pecuniary interest therein, if any.
F2 Each share of Series A Preferred Stock is automatically convertible into one share of Common Stock at the close of the Issuer's initial public offering and has no expiration date.
F3 Each share of Series B Preferred Stock is automatically convertible into one share of Common Stock at the close of the Issuer's initial public offering and has no expiration date.
F4 The option vests as to 1/36th of the total shares on each monthly anniversary, beginning on June 23, 2021, subject to the Reporting Person's provision of service to the Issuer on each vesting date.